6533b822fe1ef96bd127d731

RESEARCH PRODUCT

Real-world evidence from a European cohort study of patients with treatment resistant depression:Healthcare resource utilization

S. De GiorgiG. DegraeveGianluca RossoPilar SierraV. Perez SolaK. HeerleinS. RathodThomas FrodlAlbino J. Oliveira-maiaY. KambarovB. RiveChristian OtteJ. MorrensS. Mulhern HaugheyW. HagedoornAntonio VitaAllan H. Young

subject

Healthcare resource utilization Major depressive disorder Observational study Real-world evidence Treatment resistant depressionmedicine.medical_specialtyMajor depressive disorderTreatment resistant depressionCohort StudiesIndirect costsDepressive Disorder Treatment-ResistantHealthcare resource utilization; Major depressive disorder; Observational study; Real-world evidence; Treatment resistant depressionObservational studyHealth careHealthcare resource utilizationmedicineHumansMajor depressive episodeDepression (differential diagnoses)Retrospective StudiesReal-world evidenceDepressive DisorderDepressive Disorder Majorbusiness.industryTreatment-ResistantMajorHealth Care Costsmedicine.diseasePsychiatry and Mental healthClinical PsychologyEmergency medicineMajor depressive disorderObservational studymedicine.symptombusinessHealthcare resource utilization; Major depressive disorder; Observational study; Real-world evidence; Treatment resistant depression; Cohort Studies; Delivery of Health Care; Health Care Costs; Humans; Retrospective Studies; Depressive Disorder Major; Depressive Disorder Treatment-ResistantTreatment-resistant depressionDelivery of Health CareCohort study

description

Journal of affective disorders 298, Part A 442-450 (2022). doi:10.1016/j.jad.2021.11.004 special issue: "Special Issue on Corona Virus / Edited by Allan Young, Ron Acierno, Xiang Yang Zhang"

yearjournalcountryeditionlanguage
2022-02-01
10.1016/j.jad.2021.11.004https://kclpure.kcl.ac.uk/ws/files/175765192/Real_world_evidence_from_HEERLEIN_Publishedonline17November2021_GOLD_VoR_CC_BY.pdf